Differential diagnosis of gastrointestinal stromal tumor by histopathology and immunohistochemistry

Figure 5 Leiomyoma (×200). (A) HE staining; (B) desmin IHC; (C) KIT IHC; (D) S100P IHC. IHC, immunohistochemistry.

Read More>>

Utility and performance characteristics of a novel submucosal injection agent (EleviewTM) for endoscopic mucosal resection and endoscopic submucosal dissection

Figure 1 Performance of cecal EMR using EleviewTM. (A) Cecal polyp spanning across a fold, without any suspicious or high-risk features; (B) injection of EleviewTM for submucosal lifting; (C) mucosal resection of the polyp using snare; (D) post-EMR defect, which was then closed with hemoclips. EMR, endoscopic mucosal resection.

Read More>>

Asian consensus guidelines for gastrointestinal stromal tumor: what is the same and what is different from global guidelines

Figure 3 Genotypes of GIST. Carney-Stratakis syndrome is a dyad of paraganglioma and gastric GIST with autosomal dominance. Carney triad is characterized by three neoplasms of gastric GIST, pulmonary chondroma, and extra-adrenal paraganglioma. A part of the algorithm is similar to (25). #, indicates syndromic GIST. GIST, gastrointestinal stromal tumor; SDH, succinate dehydrogenase; NF1, neurofibromatosis type 1.

Read More>>

TGH Annual Report 2017

We are glad to present the 2017 Annual Report of TGH here. In the year of 2017, TGH has made some progress by the join-efforts of all contributors. More information is shown in the Annual Report.

We also would like to give our sincere thanks to all editorial board members, reviewers, authors and readers. Wish you all a happy, healthy and prosperous 2018!

Read More>>

Modifications in the International Study Group for Pancreatic Surgery (ISGPS) definition of postoperative pancreatic fistula

Figure 1. Change in POPF diagnosis. POPF, postoperative pancreatic fistula; ISGPF, the International Study Group of Pancreatic Fistula.

Read More>>

Trans-arterial radio-embolization: a new chance for patients with hepatocellular cancer to access liver transplantation, a world review

Table 1. World reported series of liver transplantation after Y90-RE

Read More>>

Hepatocellular cancer and recurrence after liver transplantation: what about the impact of immunosuppression?

Table 2. Influence of immunosuppressive drugs on (de novo) tumour development.

Read More>>

Function-preserving surgery for gastric cancer: current status and future perspectives

Figure 1. The distal stomach was divided while remaining a 4–5 cm pyloric cuff. The proximal remnant stomach was then revised just proximal to demarcation line between the right and left gastroepiploic artery.

Read More>>

The growing impact of alpha-fetoprotein in the field of liver transplantation for hepatocellular cancer: time for a revolution

Table 2. Recommendations on the prognostic role of alpha-fetoprotein as reported in the most recent international guidelines on hepatocellular cancer management

Read More>>

Hepatocellular carcinoma: when is liver transplantation oncologically futile?

Figure 1. A proposed algorithm for selection of patients for liver transplantation based on the BCLC tumor stage and on risk factors indicating unfavourable tumor biology. BCLC, Barcelona clinic liver cancer; AFP, alpha-fetoprotein; PET, positron emission tomography.

Read More>>